Basic Information
Basic information for FTX-261-36aa
Peptide Name FTX-261-36aa
Genome Position chrX:74202911-74203018[-]
Species Human
Peptide Sequence MVPIDTDIRVGKDFVHRPKTLKGKSFHFGKGDIDFV
Peptide Length 36
Unique No (FTX-202-36aa,FTX-210-36aa,FTX-218-36aa,FTX-223-36aa,FTX-224-36aa,FTX-228-36aa,FTX-229-36aa,FTX-231-36aa,FTX-233-36aa,FTX-236-36aa,FTX-238-36aa,FTX-241-36aa,FTX-245-36aa,FTX-257-36aa,FTX-264-36aa,FTX-265-36aa,FTX-266-36aa,FTX-268-36aa)
Grand Average of Hydropathicity -0.3389
Relative Molecular Mass 4732.37
Experimental Evidences 1:m6A
lncRNA ID/Name ENSG00000230590;FTX
Transcript ID/Name ENST00000664123;FTX-261
Transcript Length 1925
Coding Ability 0.5668
DNA Sequence Corresponding to Peptide ATGGTTCCCATTGATACAGACATTAGAGTGGGAAAGGACTTCGTTCATAGACCGAAGACCCTCAAAGGAAAGTCCTTCCATTTTGGGAAGGGTGACATTGATTTCGTT
Experimental Evidences
   m6A
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :